临床药理学咨询及其在临床决策中的实施情况
该研究评估了269例临床药理学咨询的特征,比较不同专科的咨询类型,并评价建议的依从性。多数咨询来自赫尔辛基大学医院(57%),主要来自精神科(49%)和内科(19%)。药物不良反应是精神科和内科的常见主题,药物相互作用在其他专科更常见。86%的咨询建议被遵循,仅3.3%未遵循。
要点
- 临床药理学咨询主要来自精神科和内科,药物不良反应和相互作用是常见主题。
- 86%的咨询建议被临床医生遵循,仅3.3%未遵循。
- 咨询对患者治疗有实质性影响,为独立工作的临床医生提供支持。
核心结论
- 临床药理学咨询对患者治疗有实质性影响,且为临床医生提供有价值的临床和科学支持。
研究设计与样本
- 通过评估患者数据文件收集人口学数据,确定咨询医学专科、咨询来源,并评估咨询特征;进一步分析将后续行动与咨询回复中的建议进行比较。共纳入269例咨询查询。
主要发现
- 多数咨询来自赫尔辛基大学医院(57%),主要来自精神科(49%)、内科(19%)和其他专科(32%)。
- 精神科和内科最常见的主题是药物不良反应,其他专科最常见的是药物相互作用。
- 药物不良反应主题的比例在精神科(50%)和其他专科(30%)之间差异有统计学意义(p=0.004)。
- 药物相互作用主题的比例在其他专科(40%)和精神科(20%)之间差异有统计学意义(p=0.010)。
- 与解剖治疗化学分类N类(神经系统)相关的问题出现在68%的病例中。
关键数值与推荐
- 咨询建议在86%的病例中被遵循,仅3.3%被分类为「未遵循建议」。
- 在其余咨询病例中,无法评估依从性(8.6%)或情况已变化导致建议未实施(1.5%)。
临床怎么用
- 临床药理学咨询可显著影响患者治疗决策,临床药师可参考此模式为临床医生提供建议支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: One of the key roles of clinical pharmacologists is to work as consultants for other medical specialties. We wanted to investigate the characteristics of clinical pharmacology consultations, compare the types of consultations from different specialties, and evaluate how well the recommendations given were followed. METHODS: Patient data files were assessed to collect demographic data, to determine the consulting medical specialty, origin of consultation, and to evaluate the characteristics of consultations. In a further analysis, subsequent actions were compared with recommendations provided in the consultation responses. RESULTS: Of the 269 consultations queries, the majority originated from Helsinki University Hospital (57%). They mostly came from psychiatry (49%), general medicine (19%), and from other specialties (32%). The most frequent topic was adverse drug reactions (ADRs) in psychiatry and general medicine and drug interactions in other specialties. The proportion of ADR topics differed between psychiatry (50%) and other specialties (30%, p = 0.004) and drug interaction topics between other specialties (40%) and psychiatry (20%, p = 0.010). Questions related to the Anatomical Therapeutic Chemical class N (nervous system) appeared in 68% of cases. Consultation instructions were followed in 86% of cases, with only 3.3% classified as 'Instructions were not followed'. In the remaining consultation cases, it was not possible to evaluate adherence (8.6%) or the circumstances had changed so that the recommendation was not implemented (1.5%). CONCLUSIONS: Analysis of patient data files indicates that clinical pharmacology consultations substantially affect how patients are treated. Furthermore, this service offers valuable clinical and scientific support for clinicians working independently.
引用
- Kauppila M, Backman JT, Lapatto-Reiniluoto O, et al. Clinical pharmacology consultations and their implementation in clinical decision making. Br J Clin Pharmacol. 2025. PMID: 41257316. doi:10.1002/bcp.70337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。